Generate Biomedicines, Inc. (GENB)
17.71
+1.59
(+9.86%)
USD |
NASDAQ |
Aug 24, 16:00
17.62
-0.09
(-0.51%)
After-Hours: 20:00
Generate Biomedicines Gross Profit Margin (Quarterly) : 48.94% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 48.94% |
| March 31, 2026 | 54.69% |
| Date | Value |
|---|---|
| June 30, 2025 | 67.21% |
| March 31, 2025 | 61.28% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Twist Bioscience Corp. | 52.76% |
| Prime Medicine, Inc. | -54.68% |
| Intellia Therapeutics, Inc. | 72.58% |
| Beam Therapeutics, Inc. | -1.00K% |
| Moderna, Inc. | -7.59% |
Gross Profit Margin (Quarterly) Related Metrics
| Profit Margin (Quarterly) | -1.07K% |
| Operating Margin (Quarterly) | -1.13K% |